Nascent Biotech will be a key sponsor of the 2015 edition of the Human Antibodies & Hybridomas Conference, held October 28-30, 2015, at the University of Lausanne/CHUV, in Lausanne, Switzerland.
Nascent Biotech CEO Mark Glassy will serve as the program chairman of the Scientific Advisory Committee.
The conference scope will include:
Infectious Diseases · Autoimmunity · Molecular Biology · Emerging Technologies · Clinical Applications · Therapeutic Antibodies · Cancer · Anti-Infective Antibodies · Intellectual Property & Legal Issues
New special session devoted to:
‘ALS and Antibodies’
Recent Posts
